Vernalis Therapeutics
Berwyn, Pennsylvania based Vernalis Therapeutics, Inc. is a distributor of pharmaceutical products, with a focus on the sales and marketing of branded prescription products in the US market. Vernalis Therapeutics, Inc. is a US subsidiary of Vernalis plc, a UK based company, listed on AIM and founded in 2003 with an historic focus on drug discovery and clinical development.
Vernalis Therapeutics, Inc. is dedicated to building a broad portfolio of unique long-acting formulations of branded prescription cough cold products for the US market.
In October 2015, Vernalis also acquired the US rights to Moxatag®, a once-a-day amoxicillin for strep throat in adult and pediatric patients 12 years of age or older.
